Clinical Immunization Safety Assessment IDIQ

Amendment 2. The purpose of this Amendment is to:

1. Change the proposal due date to May 19, 2023

2. Delete Task 3 from the Sample Task Order

3. Clarify/update proposal instructions

4. Change/update numerous Clauses and Provisions

A copy of the Revised IDIQ solicitation and Sample Task Order solicitation have been uploaded.

__________________________________

The purpose of this indefinite delivery, indefinite quantity (IDIQ) contract is to provide the Centers for Disease Control and Prevention (CDC), National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division of Healthcare Quality Promotion (DHQP), Immunization  Safety Office (ISO), an “as needed” mechanism to obtain required services through the issuance of individual task orders in support  of vaccine safety monitoring and evaluation that meet public health priorities for CDC.  The Contractor independently, and not as an agent of the United States Government, shall furnish personnel, facilities, supplies and equipment (except that specifically addressed within the individual task order) necessary to perform the individual Task Orders under the contract.

Goals

1)    Serve as a vaccine safety resource for U.S. healthcare providers with complex vaccine safety questions about a specific patient to assist with immunization decision-making 
2)    Assist the Centers for Disease Control and Prevention (CDC) and its partners in evaluating emerging vaccine safety issues 
3)    Conduct clinical research studies to better understand vaccine safety and identify preventive strategies for AEFI
 

The Contractor shall provide all labor, supervision, equipment, materials, supplies, travel, transportation, and perform all work necessary to provide public health, scientific, and technical services in support of advancing vaccine safety activities, as specifically required under individual Task Orders under this contract.  

The two main requirements for this CISA IDIQ contract include:

1. Clinical case reviews and evaluation of vaccine safety issues, and coordination activities to support this function. 
2. Research studies to advance knowledge of vaccine safety and inform clinical and public health practices.
 

Awardees must be medical research centers that provide clinical care to patients and could recruit participants for clinical research studies.